Serum albumin at resection predicts in-hospital death, while serum lactate and aPTT on the first postoperative day anticipate anastomotic leakage after Ivor-Lewis-esophagectomy.
Anastomotic leakage
Death
Ivor-Lewis-esophagectomy
Morbidity
Mortality
Serum lactate
aPTT
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
09
12
2021
accepted:
08
04
2022
pubmed:
29
4
2022
medline:
15
9
2022
entrez:
28
4
2022
Statut:
ppublish
Résumé
Anastomotic leakage (AL) is a major complication after esophagectomy, potentiating morbidity and mortality. There are several patient risk factors associated with AL, but high-fidelity postoperative predictors are still under debate. The aim was to identify novel reliable predictors for AL after esophagectomy. A high-volume single-center database study, including 138 patients receiving Ivor-Lewis-esophagectomy between 2017 and 2019, was performed. Serum levels of albumin, aPTT, and lactate before and after surgery were extracted to assess their impact on AL and in-hospital mortality. High serum lactate on postoperative day 1 (POD1) could be shown to predict AL after esophagectomy [AL vs. no AL: 1.2 (0.38) vs. 1.0 (0.37); p < 0.001]. Accordingly, also differences of serum lactate level between end (POD0-2) and start of surgery (POD0-1) (p < 0.001) as well as between POD1 and POD0-1 (p < 0.001) were associated with AL. Accordingly, logistic regression identified serum lactate on POD 1 as an independent predictor of AL [HR: 4.37 (95% CI: 1.28-14.86); p = 0.018]. Further, low serum albumin on POD0 [2.6 (0.53) vs. 3.1 (0.56); p = 0.001] and high serum lactate on POD 0-1 [1.1 (0.29) vs. 0.9 (0.30); p = 0.043] were associated with in-hospital death. Strikingly, logistic-regression (HR: 0.111; p = 0.008) and cox-regression analysis (HR: 0.118; p = 0.003) showed low serum albumin as an independently predictor for in-hospital death after esophagectomy. This study identified high serum lactate as an independent predictor of AL and low serum albumin as a high-fidelity predictor of in-hospital death after esophagectomy. These parameters can facilitate improved postoperative treatment leading to better short-term as well as long-term outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Anastomotic leakage (AL) is a major complication after esophagectomy, potentiating morbidity and mortality. There are several patient risk factors associated with AL, but high-fidelity postoperative predictors are still under debate. The aim was to identify novel reliable predictors for AL after esophagectomy.
METHODS
METHODS
A high-volume single-center database study, including 138 patients receiving Ivor-Lewis-esophagectomy between 2017 and 2019, was performed. Serum levels of albumin, aPTT, and lactate before and after surgery were extracted to assess their impact on AL and in-hospital mortality.
RESULTS
RESULTS
High serum lactate on postoperative day 1 (POD1) could be shown to predict AL after esophagectomy [AL vs. no AL: 1.2 (0.38) vs. 1.0 (0.37); p < 0.001]. Accordingly, also differences of serum lactate level between end (POD0-2) and start of surgery (POD0-1) (p < 0.001) as well as between POD1 and POD0-1 (p < 0.001) were associated with AL. Accordingly, logistic regression identified serum lactate on POD 1 as an independent predictor of AL [HR: 4.37 (95% CI: 1.28-14.86); p = 0.018]. Further, low serum albumin on POD0 [2.6 (0.53) vs. 3.1 (0.56); p = 0.001] and high serum lactate on POD 0-1 [1.1 (0.29) vs. 0.9 (0.30); p = 0.043] were associated with in-hospital death. Strikingly, logistic-regression (HR: 0.111; p = 0.008) and cox-regression analysis (HR: 0.118; p = 0.003) showed low serum albumin as an independently predictor for in-hospital death after esophagectomy.
CONCLUSIONS
CONCLUSIONS
This study identified high serum lactate as an independent predictor of AL and low serum albumin as a high-fidelity predictor of in-hospital death after esophagectomy. These parameters can facilitate improved postoperative treatment leading to better short-term as well as long-term outcomes.
Identifiants
pubmed: 35482049
doi: 10.1007/s00423-022-02510-y
pii: 10.1007/s00423-022-02510-y
pmc: PMC9468131
doi:
Substances chimiques
Lactates
0
Serum Albumin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2309-2317Informations de copyright
© 2022. The Author(s).
Références
J Am Coll Surg. 2004 Jan;198(1):42-50
pubmed: 14698310
Dis Esophagus. 2020 Mar 16;33(3):
pubmed: 31957798
Endoscopy. 2020 Aug;52(8):632-642
pubmed: 32316043
Ann Surg. 2011 May;253(5):890-9
pubmed: 21394013
Langenbecks Arch Surg. 2016 Sep;401(6):805-12
pubmed: 27468910
Dis Esophagus. 2017 Jun 1;30(6):1-12
pubmed: 28475743
Endoscopy. 2017 May;49(5):498-503
pubmed: 28107761
J Gastrointest Oncol. 2021 Feb;12(1):207-215
pubmed: 33708437
Surgery. 2016 Nov;160(5):1294-1301
pubmed: 27521045
Ann Thorac Surg. 2013 Jan;95(1):292-8
pubmed: 23200235
Int J Surg. 2017 Oct;46:7-10
pubmed: 28803998
Ann Surg Oncol. 2009 Apr;16(4):1017-25
pubmed: 19189186
J Am Coll Surg. 2007 Dec;205(6):735-40
pubmed: 18035255
World J Surg. 2003 Sep;27(9):1058-61
pubmed: 12925905
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Thorac Surg Clin. 2015 Nov;25(4):449-59
pubmed: 26515945
Surg Today. 2016 Oct;46(10):1138-45
pubmed: 26818192
Thorac Cardiovasc Surg. 2018 Aug;66(5):376-383
pubmed: 28511246
Surgery. 2016 Jul;160(1):191-203
pubmed: 27067160
Ann Surg Oncol. 2020 Jul;27(7):2132-2134
pubmed: 32052298
J Gastrointest Surg. 2019 Jan;23(1):67-75
pubmed: 30374816
J Am Coll Surg. 1994 Jul;179(1):80-3
pubmed: 8019732
Ann Surg. 2008 Jan;247(1):71-6
pubmed: 18156925
Ann Surg. 2010 Jun;251(6):1064-9
pubmed: 20485137
Ann Surg. 2015 Aug;262(2):286-94
pubmed: 25607756
Ann Thorac Med. 2009 Oct;4(4):197-200
pubmed: 19881165
Nutr Cancer. 2015;67(3):481-5
pubmed: 25706773
Dis Esophagus. 2018 Nov 1;31(11):
pubmed: 29939229
Br J Surg. 2001 Oct;88(10):1346-51
pubmed: 11578290
Ann Surg. 2015 Dec;262(6):972-80
pubmed: 26469952